Quick Verdict

Tesamorelin drives stronger fat loss via GH receptor activation (FDA-approved for lipodystrophy). AOD-9604 offers targeted lipolysis without GH receptor binding — ideal for subjects who need fat loss without GH-axis concerns.

Side-by-Side Analysis

DimensionAOD-9604Tesamorelin
MechanismMimics GH fat-burning domain.Stimulates GH for fat metabolism.
Primary BenefitsFat loss without GH side effectsVisceral fat reduction, body recomposition
Typical Dose300–300mcg1000–1000mcg
RouteSubQSubQ
Frequency7x/wk7x/week
Half-Life1 hours0.43 hours
FDA StatusResearch OnlyApproved
Evidence Gradepreclinicalvery-strong
Key Studies18+ indexed20+ indexed
Lowest Price$49.99 / 5mg via Amino Club$69.99 / 10mg via Amino Club

Which one should you choose?

Tesamorelin produces substantially greater fat loss via powerful GH spikes; AOD-9604 offers a safer, gentler lipolytic effect without affecting blood sugar. Tesamorelin is FDA-approved for visceral fat and works by triggering massive GH release (activating the full GH receptor pathway). AOD-9604 is a GH fragment (177-191) that directly stimulates beta-3 adrenergic receptors in fat tissue — bypassing the growth receptor entirely. Choose Tesamorelin for aggressive visceral fat reduction. Choose AOD-9604 if you need fat loss without any GH-axis stimulation (e.g., active cancer concerns, blood sugar sensitivity).

Who Should Choose AOD-9604?

Choose AOD-9604 if you:

  • Want direct lipolysis without GH receptor stimulation
  • Are sensitive to blood sugar disruption from GH elevation
  • Are researching fat loss as an add-on to an existing GH protocol
  • Need a very mild, well-tolerated fat loss agent

Who Should Choose Tesamorelin?

Choose Tesamorelin if you:

  • Want the most aggressive visceral fat reduction available
  • Are comfortable with the full GHRH mechanism and GH stimulation
  • Are researching lipodystrophy or metabolic syndrome specifically
  • Want an FDA-approved mechanism with clinical trial data

Can you stack AOD-9604 + Tesamorelin?

These can be stacked carefully. AOD-9604 acts peripherally on fat cells; Tesamorelin acts centrally via the pituitary. The combination may produce additive fat loss effects. However, researchers should monitor IGF-1 and blood glucose when stacking any GH-axis peptide.

Vendor Pricing

· Affiliate links · Prices verified 2026

AOD-9604

2 vendors
Amino ClubEditor's Pick Best Value
5mg vial · $10.00/mg
$49.99Buy
Ascension Peptides
5mg vial · $12.00/mg
$59.99Buy

Tesamorelin

3 vendors
Amino ClubEditor's Pick Best Value
10mg vial · $7.00/mg
$69.99Buy
Ascension Peptides
5mg vial · $16.00/mg
$80.00Buy
Bio Longevity Labs
10mg vial · $9.00/mg
$89.98Buy

Affiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.

Frequently Asked Questions

No — this is AOD-9604's key advantage. It does not bind the GH receptor and does not raise IGF-1 or affect blood sugar, unlike full-length GH or GHRH analogs like Tesamorelin.

Related Comparisons

⚠ Educational only · Not medical advice · Research compounds not approved by FDA for human consumption